PMFA
SUPN icon

Plante Moran Financial Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Plante Moran Financial Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$605 Buy
+13
New +$624 ﹤0.01% 1066
2016
Q4 		– Sell
-1,066
Closed -$26K – 1033
2016
Q3 		$26K Buy
+1,066
New +$24.1K 0.02% 435
2016
Q1 		– Sell
-67
Closed -$1K – 1018
2015
Q4 		$1K Buy
+67
New +$1.04K ﹤0.01% 917

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Plante Moran Financial Advisors's SUPN Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 13 shares worth $605. The stake represents ﹤0.01% of the portfolio and ranks #1066 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in SUPN as recently as Q3 2016.

Plante Moran Financial Advisors first reported a position in SUPN in Q4 2015 and has held it in 3 quarters since. The position peaked at $26K in Q3 2016. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Plante Moran Financial Advisors held 13 shares of Supernus Pharmaceuticals worth $605 as of Q2 2026.
  • Supernus Pharmaceuticals was a new Plante Moran Financial Advisors position in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #1066 holding.
  • Plante Moran Financial Advisors first reported a position in Supernus Pharmaceuticals in Q4 2015 and has held it in 3 quarters since.
  • Plante Moran Financial Advisors's Supernus Pharmaceuticals position peaked at $26K in Q3 2016.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.